Resumen de acción TLRY
Tilray Brands, Inc. se dedica a la investigación, cultivo, procesamiento y distribución de productos de cannabis medicinal en Canadá, Estados Unidos, Europa, Australia, Nueva Zelanda, América Latina y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Tilray Brands, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.75 |
| 52 Week High | US$3.40 |
| 52 Week Low | US$1.50 |
| Beta | 2.46 |
| 1 Month Change | -24.24% |
| 3 Month Change | -8.38% |
| 1 Year Change | -26.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -89.13% |
Noticias y actualizaciones recientes
Recent updates
Tilray Could Break Down
Apr 07Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up
Mar 27
Tilray: Big Opportunities Ahead In Germany And Alcohol Segment
Mar 12Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt
Jan 25Tilray Remains Stuck In Neutral
Jan 10Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking
Dec 19Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%
Oct 10Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results
Oct 06Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate
Sep 18Little Excitement Around Tilray Brands, Inc.'s (NASDAQ:TLRY) Revenues
Apr 17An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 28% Undervalued
Feb 03Tilray Brands, Inc.'s (NASDAQ:TLRY) Intrinsic Value Is Potentially 97% Above Its Share Price
Oct 09Tilray and other cannabis stocks soar as Biden calls for marijuana scheduling review
Oct 06Japan should permit medical cannabis, health ministry panel says
Sep 29Most Canadian cannabis LPs not following Aurora's decline after earnings disappointment
Sep 21Tilray's Canadian cannabis brand RIFF launches Drumsticks
Sep 15Tilray: Hype Train Crashed
Sep 08Rentabilidad de los accionistas
| TLRY | US Pharmaceuticals | Mercado US | |
|---|---|---|---|
| 7D | 1.7% | 0.08% | 1.2% |
| 1Y | -26.8% | 13.2% | 24.9% |
Rentabilidad vs. Industria: TLRY underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Rentabilidad vs. Mercado: TLRY underperformed the US Market which returned 24.9% over the past year.
Volatilidad de los precios
| TLRY volatility | |
|---|---|
| TLRY Average Weekly Movement | 13.0% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: TLRY's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: TLRY's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | 1,600 | Irwin Simon | www.tilray.com |
Tilray Brands, Inc. se dedica a la investigación, cultivo, procesamiento y distribución de productos de cannabis medicinal en Canadá, Estados Unidos, Europa, Australia, Nueva Zelanda, Latinoamérica y a escala internacional. La empresa opera a través de cuatro segmentos: Negocio de Cannabis, Negocio de Distribución, Negocio de Bebidas Alcohólicas y Negocio de Bienestar. También ofrece productos de cannabis de uso médico y para adultos; compra y revende productos farmacéuticos y de bienestar; y produce, comercializa, vende y distribuye bebidas alcohólicas, alimentos a base de cáñamo y otros productos de bienestar.
Resumen de fundamentos de Tilray Brands, Inc.
| Estadísticas fundamentales de TLRY | |
|---|---|
| Capitalización bursátil | US$1.42b |
| Beneficios(TTM) | -US$351.95m |
| Ingresos (TTM) | US$743.25m |
1.8x
Ratio precio-ventas (PS)-3.8x
Ratio precio-beneficio (PE)¿Está TLRY sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de TLRY | |
|---|---|
| Ingresos | US$743.25m |
| Coste de los ingresos | US$521.77m |
| Beneficio bruto | US$221.48m |
| Otros gastos | US$573.42m |
| Beneficios | -US$351.95m |
Últimos beneficios comunicados
Feb 29, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.45 |
| Margen bruto | 29.80% |
| Margen de beneficio neto | -47.35% |
| Ratio deuda/patrimonio | 12.1% |
¿Cómo se ha desempeñado TLRY a largo plazo?
Ver rendimiento histórico y comparativa